Skip to main content
. 2022 Jun 14;28(5):760–768. doi: 10.1111/hae.14588

TABLE 2.

Three types of community‐prioritised inherited BD research themes

Category Prioritised themes
Themes applicable across inherited BDs
  • Research that is feasible, prioritised for impact on patient outcomes

  • Research to benefit future generations addressing the most pressing needs of the inherited BD community

  • Impact of inherited BD symptoms/manifestations across the lifespan

  • Therapies for non‐haemophilia inherited BDs that are safe/effective/easy to use/affordable/covered by insurance; and for RBDs, disease‐specific; POC management

  • Pain management in PWIBD

  • Mental health in PWIBD

  • Health disparities across under‐represented populations (ethnic, racial, gender [including LGBTQ], and geographic)

  • Future workforce development and evolution of the HTC model to ensure/optimise future care of PWIBD

Priorities specific to individual inherited BDs
  • Rare and ultra‐rare inherited BDs:

    • Disease‐specific diagnostics and therapeutics, including recombinant replacement concentrates

    • Impact of inherited BD symptoms/manifestations across the lifespan

  • Women with inherited BDs:

    • Novel therapeutics for VWD

    • Impact of inherited BD symptoms/manifestations across the lifespan

    • Joint disease in women

    • Haemophilia carriers

  • Haemophilia:

    • Continuing therapeutic advance (efficacy/safety/ease of administration) toward normal QoL

    • Defining ‘cure’ expectations with gene therapy

    • Moderate/mild haemophilia research (non‐severe)

Infrastructure and capacity opportunities
  • Elements of national research infrastructure/capacitation/acculturation facilitating and optimising work on a prioritised research blueprint through:

    • National patient‐centred data collection

    • Hypothesis‐driven and feasible basic research/observational studies/clinical and implementation trials

    • Future workforce nourishing an expansive national research enterprise through:

      • Inclusion of an entire, well‐trained inherited BD provider and patient community

      • Regional, national, and international collaborations

      • Multidisciplinary team science drawing expertise from within and outside the inherited BD scientific community

      • Strategic partnerships leveraging existing infrastructure and common goals

  • NHF role in realising the National Blueprint for Inherited Bleeding Disorders Research

Abbreviations: BD, bleeding disorder; HTC, haemophilia treatment centre; LGBTQ, lesbian, gay, bisexual, transgender, queer; NHF, National Hemophilia Foundation; POC, point of care; PWIBD, people with an inherited bleeding disorder; QoL, quality of life; RBD, rare bleeding disorder; VWD, von Willebrand disease.